 | • レポートコード：QYR2104Z1598 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗ウイルス剤、モノクローナル抗体、キナーゼ阻害剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症治療薬の種類別市場規模（コルチコステロイド、抗ウイルス剤、モノクローナル抗体、キナーゼ阻害剤、その他） ・新型コロナウイルス感染症治療薬の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・新型コロナウイルス感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Serum Institute of India、Pfizer Inc、AstraZeneca Plc、Bharat Biotech International Limited、Cadila Healthcare Limited、Johnson & Johnson、Moderna、GlaxoSmithKline Plc、CanSino Biologics、Sinovac Biotech、Novavax, Inc、Glenmark Pharmaceuticals Limited、Dr. Reddy's Laboratories、Merck & Co., Inc） ・結論 |
The coronavirus (COVID-19) is an infectious disease caused by the novel coronavirus. Those affected by COVID-19 are likely to experience mild to moderate respiratory illness and recover without requiring special treatment, but people in the age group of 50 years and above, and those and suffering from other health disorders such as hypertension, diabetes, and kidney failure are at a severe risk of infection and require specific treatment. Moreover, currently there is no medication for treating the coronavirus, and health physicians are suggesting corticosteroids, anti-viral therapies for individuals with severe symptoms.
Market Analysis and Insights: Global Coronavirus Treatment Drugs Market
The global Coronavirus Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Coronavirus Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Coronavirus Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Coronavirus Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Coronavirus Treatment Drugs market.
Global Coronavirus Treatment Drugs Scope and Market Size
Coronavirus Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Coronavirus Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Corticosteroids
Anti-viral
Monoclonal Antibodies
Kinase Inhibitors
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Serum Institute of India
Pfizer Inc
AstraZeneca Plc
Bharat Biotech International Limited
Cadila Healthcare Limited
Johnson & Johnson
Moderna
GlaxoSmithKline Plc
CanSino Biologics
Bharat Biotech International Limited
Cadila Healthcare Limited
Glenmark Pharmaceuticals Limited
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Anti-viral
1.2.4 Monoclonal Antibodies
1.2.5 Kinase Inhibitors
1.2.6 Others
1.3 Market by Application
1.3.1 Global Coronavirus Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Coronavirus Treatment Drugs Market Perspective (2016-2027)
2.2 Coronavirus Treatment Drugs Growth Trends by Regions
2.2.1 Coronavirus Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Coronavirus Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Coronavirus Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Coronavirus Treatment Drugs Industry Dynamic
2.3.1 Coronavirus Treatment Drugs Market Trends
2.3.2 Coronavirus Treatment Drugs Market Drivers
2.3.3 Coronavirus Treatment Drugs Market Challenges
2.3.4 Coronavirus Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Coronavirus Treatment Drugs Players by Revenue
3.1.1 Global Top Coronavirus Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Coronavirus Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Coronavirus Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Coronavirus Treatment Drugs Revenue
3.4 Global Coronavirus Treatment Drugs Market Concentration Ratio
3.4.1 Global Coronavirus Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Treatment Drugs Revenue in 2020
3.5 Coronavirus Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Coronavirus Treatment Drugs Product Solution and Service
3.7 Date of Enter into Coronavirus Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Coronavirus Treatment Drugs Breakdown Data by Type
4.1 Global Coronavirus Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2022-2027)
5 Coronavirus Treatment Drugs Breakdown Data by Application
5.1 Global Coronavirus Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Coronavirus Treatment Drugs Market Size (2016-2027)
6.2 North America Coronavirus Treatment Drugs Market Size by Type
6.2.1 North America Coronavirus Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Coronavirus Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Coronavirus Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Coronavirus Treatment Drugs Market Size by Application
6.3.1 North America Coronavirus Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Coronavirus Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Coronavirus Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Coronavirus Treatment Drugs Market Size by Country
6.4.1 North America Coronavirus Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Coronavirus Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Coronavirus Treatment Drugs Market Size (2016-2027)
7.2 Europe Coronavirus Treatment Drugs Market Size by Type
7.2.1 Europe Coronavirus Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Coronavirus Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Coronavirus Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Coronavirus Treatment Drugs Market Size by Application
7.3.1 Europe Coronavirus Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Coronavirus Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Coronavirus Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Coronavirus Treatment Drugs Market Size by Country
7.4.1 Europe Coronavirus Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Coronavirus Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Coronavirus Treatment Drugs Market Size (2016-2027)
9.2 Latin America Coronavirus Treatment Drugs Market Size by Type
9.2.1 Latin America Coronavirus Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Coronavirus Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Coronavirus Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Coronavirus Treatment Drugs Market Size by Application
9.3.1 Latin America Coronavirus Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Coronavirus Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Coronavirus Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Coronavirus Treatment Drugs Market Size by Country
9.4.1 Latin America Coronavirus Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Coronavirus Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Serum Institute of India
11.1.1 Serum Institute of India Company Details
11.1.2 Serum Institute of India Business Overview
11.1.3 Serum Institute of India Coronavirus Treatment Drugs Introduction
11.1.4 Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.1.5 Serum Institute of India Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Details
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Coronavirus Treatment Drugs Introduction
11.2.4 Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.2.5 Pfizer Inc Recent Development
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Details
11.3.2 AstraZeneca Plc Business Overview
11.3.3 AstraZeneca Plc Coronavirus Treatment Drugs Introduction
11.3.4 AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.3.5 AstraZeneca Plc Recent Development
11.4 Bharat Biotech International Limited
11.4.1 Bharat Biotech International Limited Company Details
11.4.2 Bharat Biotech International Limited Business Overview
11.4.3 Bharat Biotech International Limited Coronavirus Treatment Drugs Introduction
11.4.4 Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.4.5 Bharat Biotech International Limited Recent Development
11.5 Cadila Healthcare Limited
11.5.1 Cadila Healthcare Limited Company Details
11.5.2 Cadila Healthcare Limited Business Overview
11.5.3 Cadila Healthcare Limited Coronavirus Treatment Drugs Introduction
11.5.4 Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.5.5 Cadila Healthcare Limited Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Coronavirus Treatment Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Moderna
11.7.1 Moderna Company Details
11.7.2 Moderna Business Overview
11.7.3 Moderna Coronavirus Treatment Drugs Introduction
11.7.4 Moderna Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.7.5 Moderna Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Details
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Coronavirus Treatment Drugs Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 CanSino Biologics
11.9.1 CanSino Biologics Company Details
11.9.2 CanSino Biologics Business Overview
11.9.3 CanSino Biologics Coronavirus Treatment Drugs Introduction
11.9.4 CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.9.5 CanSino Biologics Recent Development
11.10 Sinovac Biotech
11.10.1 Sinovac Biotech Company Details
11.10.2 Sinovac Biotech Business Overview
11.10.3 Sinovac Biotech Coronavirus Treatment Drugs Introduction
11.10.4 Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.10.5 Sinovac Biotech Recent Development
11.11 Novavax, Inc
11.11.1 Novavax, Inc Company Details
11.11.2 Novavax, Inc Business Overview
11.11.3 Novavax, Inc Coronavirus Treatment Drugs Introduction
11.11.4 Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.11.5 Novavax, Inc Recent Development
11.12 Glenmark Pharmaceuticals Limited
11.12.1 Glenmark Pharmaceuticals Limited Company Details
11.12.2 Glenmark Pharmaceuticals Limited Business Overview
11.12.3 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Introduction
11.12.4 Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.12.5 Glenmark Pharmaceuticals Limited Recent Development
11.13 Dr. Reddy’s Laboratories
11.13.1 Dr. Reddy’s Laboratories Company Details
11.13.2 Dr. Reddy’s Laboratories Business Overview
11.13.3 Dr. Reddy’s Laboratories Coronavirus Treatment Drugs Introduction
11.13.4 Dr. Reddy’s Laboratories Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.13.5 Dr. Reddy’s Laboratories Recent Development
11.14 Merck & Co., Inc
11.14.1 Merck & Co., Inc Company Details
11.14.2 Merck & Co., Inc Business Overview
11.14.3 Merck & Co., Inc Coronavirus Treatment Drugs Introduction
11.14.4 Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2016-2021)
11.14.5 Merck & Co., Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Coronavirus Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Anti-viral
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Kinase Inhibitors
Table 6. Key Players of Others
Table 7. Global Coronavirus Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Coronavirus Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Coronavirus Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Coronavirus Treatment Drugs Market Share by Regions (2016-2021)
Table 11. Global Coronavirus Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Coronavirus Treatment Drugs Market Share by Regions (2022-2027)
Table 13. Coronavirus Treatment Drugs Market Trends
Table 14. Coronavirus Treatment Drugs Market Drivers
Table 15. Coronavirus Treatment Drugs Market Challenges
Table 16. Coronavirus Treatment Drugs Market Restraints
Table 17. Global Coronavirus Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Coronavirus Treatment Drugs Market Share by Players (2016-2021)
Table 19. Global Top Coronavirus Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coronavirus Treatment Drugs as of 2020)
Table 20. Ranking of Global Top Coronavirus Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Coronavirus Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Coronavirus Treatment Drugs Product Solution and Service
Table 24. Date of Enter into Coronavirus Treatment Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Coronavirus Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Coronavirus Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Coronavirus Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Coronavirus Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Coronavirus Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Coronavirus Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Coronavirus Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Coronavirus Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Coronavirus Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Coronavirus Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Coronavirus Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Coronavirus Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Coronavirus Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Coronavirus Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Coronavirus Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Coronavirus Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Coronavirus Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Coronavirus Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Coronavirus Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Coronavirus Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Coronavirus Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Coronavirus Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Coronavirus Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Coronavirus Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Serum Institute of India Company Details
Table 65. Serum Institute of India Business Overview
Table 66. Serum Institute of India Coronavirus Treatment Drugs Product
Table 67. Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 68. Serum Institute of India Recent Development
Table 69. Pfizer Inc Company Details
Table 70. Pfizer Inc Business Overview
Table 71. Pfizer Inc Coronavirus Treatment Drugs Product
Table 72. Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 73. Pfizer Inc Recent Development
Table 74. AstraZeneca Plc Company Details
Table 75. AstraZeneca Plc Business Overview
Table 76. AstraZeneca Plc Coronavirus Treatment Drugs Product
Table 77. AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 78. AstraZeneca Plc Recent Development
Table 79. Bharat Biotech International Limited Company Details
Table 80. Bharat Biotech International Limited Business Overview
Table 81. Bharat Biotech International Limited Coronavirus Treatment Drugs Product
Table 82. Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 83. Bharat Biotech International Limited Recent Development
Table 84. Cadila Healthcare Limited Company Details
Table 85. Cadila Healthcare Limited Business Overview
Table 86. Cadila Healthcare Limited Coronavirus Treatment Drugs Product
Table 87. Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 88. Cadila Healthcare Limited Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Coronavirus Treatment Drugs Product
Table 92. Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Moderna Company Details
Table 95. Moderna Business Overview
Table 96. Moderna Coronavirus Treatment Drugs Product
Table 97. Moderna Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 98. Moderna Recent Development
Table 99. GlaxoSmithKline Plc Company Details
Table 100. GlaxoSmithKline Plc Business Overview
Table 101. GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 102. GlaxoSmithKline Plc Recent Development
Table 103. CanSino Biologics Company Details
Table 104. CanSino Biologics Business Overview
Table 105. CanSino Biologics Coronavirus Treatment Drugs Product
Table 106. CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 107. CanSino Biologics Recent Development
Table 108. Sinovac Biotech Company Details
Table 109. Sinovac Biotech Business Overview
Table 110. Sinovac Biotech Coronavirus Treatment Drugs Product
Table 111. Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 112. Sinovac Biotech Recent Development
Table 113. Novavax, Inc Company Details
Table 114. Novavax, Inc Business Overview
Table 115. Novavax, Inc Coronavirus Treatment Drugs Product
Table 116. Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 117. Novavax, Inc Recent Development
Table 118. Glenmark Pharmaceuticals Limited Company Details
Table 119. Glenmark Pharmaceuticals Limited Business Overview
Table 120. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product
Table 121. Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 122. Glenmark Pharmaceuticals Limited Recent Development
Table 123. Dr. Reddy's Laboratories Company Details
Table 124. Dr. Reddy's Laboratories Business Overview
Table 125. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product
Table 126. Dr. Reddy's Laboratories Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 127. Dr. Reddy's Laboratories Recent Development
Table 128. Merck & Co., Inc Company Details
Table 129. Merck & Co., Inc Business Overview
Table 130. Merck & Co., Inc Coronavirus Treatment Drugs Product
Table 131. Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2016-2021) & (US$ Million)
Table 132. Merck & Co., Inc Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coronavirus Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Anti-viral Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Kinase Inhibitors Features
Figure 6. Others Features
Figure 7. Global Coronavirus Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Coronavirus Treatment Drugs Report Years Considered
Figure 12. Global Coronavirus Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Coronavirus Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Coronavirus Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Coronavirus Treatment Drugs Market Share by Regions (2022-2027)
Figure 16. Global Coronavirus Treatment Drugs Market Share by Players in 2020
Figure 17. Global Top Coronavirus Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coronavirus Treatment Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Coronavirus Treatment Drugs Revenue in 2020
Figure 19. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Coronavirus Treatment Drugs Market Share by Type (2016-2027)
Figure 23. North America Coronavirus Treatment Drugs Market Share by Application (2016-2027)
Figure 24. North America Coronavirus Treatment Drugs Market Share by Country (2016-2027)
Figure 25. United States Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Coronavirus Treatment Drugs Market Share by Type (2016-2027)
Figure 29. Europe Coronavirus Treatment Drugs Market Share by Application (2016-2027)
Figure 30. Europe Coronavirus Treatment Drugs Market Share by Country (2016-2027)
Figure 31. Germany Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Coronavirus Treatment Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Coronavirus Treatment Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Coronavirus Treatment Drugs Market Share by Region (2016-2027)
Figure 41. China Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Coronavirus Treatment Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Coronavirus Treatment Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Coronavirus Treatment Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Coronavirus Treatment Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Coronavirus Treatment Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Coronavirus Treatment Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Coronavirus Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Serum Institute of India Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 61. Pfizer Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 62. AstraZeneca Plc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 63. Bharat Biotech International Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 64. Cadila Healthcare Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 66. Moderna Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 67. GlaxoSmithKline Plc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 68. CanSino Biologics Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 69. Sinovac Biotech Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 70. Novavax, Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 71. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 72. Dr. Reddy's Laboratories Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 73. Merck & Co., Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed